1. Home
  2. CZFS vs AVTX Comparison

CZFS vs AVTX Comparison

Compare CZFS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Financial Services Inc.

CZFS

Citizens Financial Services Inc.

N/A

Current Price

$80.76

Market Cap

399.0M

Sector

Finance

ML Signal

N/A

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

N/A

Current Price

$6.75

Market Cap

426.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CZFS
AVTX
Founded
1984
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
399.0M
426.2M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
CZFS
AVTX
Price
$80.76
$6.75
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $34.80
AVG Volume (30 Days)
22.9K
★ 2.9M
Earning Date
10-30-2026
11-05-2026
Dividend Yield
★ 2.51%
N/A
EPS Growth
30.26
★ 72.07
EPS
★ 6.77
N/A
Revenue
$9,881,000.00
★ $27,813,137.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.96
★ N/A
Revenue Growth
2.82
★ 2312.27
52 Week Low
$54.21
$6.53
52 Week High
$88.88
$24.27

Technical Indicators

Market Signals
Indicator
CZFS
AVTX
Relative Strength Index (RSI) 39.65 33.14
Support Level $77.70 $6.53
Resistance Level $83.57 $8.55
Average True Range (ATR) 2.16 0.64
MACD -0.72 0.23
Stochastic Oscillator 8.86 10.40

Price Performance

Historical Comparison
CZFS
AVTX

About CZFS Citizens Financial Services Inc.

Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: